Dr. Melanie Henderson, MD, PhD
Claim this profileCHU Sainte-Justine
Studies Type 1 Diabetes
Studies Intercourse
3 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Melanie Henderson, MD, PhD is currently running
Registry
for Type 1 Diabetes
A registry of individuals with type 1 diabetes open to all patients with type 1 diabetes living in Canada will be established. The objective of this registry will be to measure the frequency and the severity of episodes of hypoglycemia. Participants will be invited to answer questionnaires about the frequency of their hypoglycemic episodes, their fear about hypoglycemia, their symptoms of hypoglycemia, the factors in cause (insulin therapy, nutrition, exercise, etc.), etc. Participation to the registry is divided in 3 phases. The first phase is mandatory for all participants. Phases 2 and 3 are optional.
Recruiting1 award N/A2 criteria
Lifestyle Promotion Intervention
for Obesity
The Dyn@mo lifestyle intervention (CHU Sainte-Justine, Quebec, Canada) targets children and adolescents aged 6 to 17 years old with cardiometabolic risk factors, such as obesity, hypertension, disorders in glucose regulation or dyslipidemia. Its primary goal is to promote physical activity and reduce sedentary time to improve childrens' cardiometabolic profile. To do so, the intervention relies on gathering data on mobility and physical activity using wearable sensors. These data provide a detailed picture of real-life conditions and physical activity levels, improving the health care professional's ability to tailor counseling. The investigators are presently in the implementation phase of this intervention.
Recruiting1 award N/A
More about Melanie Henderson, MD, PhD
Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Melanie Henderson, MD, PhD has experience with
- Group Education Visits
- Sensor Based PA Intervention
- Traditional PA Counseling
- Online Questionnaire - Phase 1
- Online Questionnaire - Phase 2
- Online Questionnaire - Phase 3
Breakdown of trials Melanie Henderson, MD, PhD has run
Intercourse
Motor Skills
Diabetes
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Melanie Henderson, MD, PhD specialize in?
Melanie Henderson, MD, PhD focuses on Type 1 Diabetes and Intercourse. In particular, much of their work with Type 1 Diabetes has involved treating patients, or patients who are undergoing treatment.
Is Melanie Henderson, MD, PhD currently recruiting for clinical trials?
Yes, Melanie Henderson, MD, PhD is currently recruiting for 2 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Melanie Henderson, MD, PhD has studied deeply?
Yes, Melanie Henderson, MD, PhD has studied treatments such as Group Education Visits, Sensor based PA intervention, Traditional PA counseling.
What is the best way to schedule an appointment with Melanie Henderson, MD, PhD?
Apply for one of the trials that Melanie Henderson, MD, PhD is conducting.
What is the office address of Melanie Henderson, MD, PhD?
The office of Melanie Henderson, MD, PhD is located at: CHU Sainte-Justine, Montreal, Quebec H3T 1C5 Canada. This is the address for their practice at the CHU Sainte-Justine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.